Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Herman

Showing results (1131-1140 of 1,237) with videos related to

Pageof 124
Sort By:
Gynecologic Oncology|March 23, 2025
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugatePaul Johannet, Matthew Flint, M Herman Chui, et al.
Gynecologic Oncology|January 2, 2021
Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary StudyThomas Boerner, Henry S Walch, Bastien Nguyen, et al.
Annals of Surgical Oncology|January 21, 2010
Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative studyCharles C Hsu, Joseph M Herman, Michele M Corsini, et al.
Biological Reviews of the Cambridge Philosophical Society|September 12, 2008
A claim in search of evidence: reply to Manger's thermogenesis hypothesis of cetacean brain structureLori Marino, Camilla Butti, Richard C Connor, et al.
Blood|September 5, 2015
Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinibClare Sun, Xin Tian, Yuh Shan Lee, et al.
Pancreas|January 13, 2018
Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant ChemoradiationJoseph M Herman, Salma K Jabbour, Steven H Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice GuidelineEdward P Balaban, Pamela B Mangu, Alok A Khorana, et al.
American Journal of Clinical Oncology|August 10, 2022
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma: Systematic Review and GuidelinesRachit Kumar, Leila Tchelebi, Christopher J Anker, et al.
International Journal of Radiation Oncology, Biology, Physics|September 16, 2014
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancerAlessio G Morganti, Massimo Falconi, Ruud G P M van Stiphout, et al.
Advances in Radiation Oncology|October 30, 2018
Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapyZhi Cheng, Lauren M Rosati, Linda Chen, et al.
Pageof 124

Showing results (1131-1140 of 1,237) with videos related to

Sort By:
Pageof 124
Gynecologic Oncology|March 23, 2025
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugatePaul Johannet, Matthew Flint, M Herman Chui, et al.
Gynecologic Oncology|January 2, 2021
Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary StudyThomas Boerner, Henry S Walch, Bastien Nguyen, et al.
Annals of Surgical Oncology|January 21, 2010
Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative studyCharles C Hsu, Joseph M Herman, Michele M Corsini, et al.
Biological Reviews of the Cambridge Philosophical Society|September 12, 2008
A claim in search of evidence: reply to Manger's thermogenesis hypothesis of cetacean brain structureLori Marino, Camilla Butti, Richard C Connor, et al.
Blood|September 5, 2015
Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinibClare Sun, Xin Tian, Yuh Shan Lee, et al.
Pancreas|January 13, 2018
Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant ChemoradiationJoseph M Herman, Salma K Jabbour, Steven H Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice GuidelineEdward P Balaban, Pamela B Mangu, Alok A Khorana, et al.
American Journal of Clinical Oncology|August 10, 2022
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma: Systematic Review and GuidelinesRachit Kumar, Leila Tchelebi, Christopher J Anker, et al.
International Journal of Radiation Oncology, Biology, Physics|September 16, 2014
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancerAlessio G Morganti, Massimo Falconi, Ruud G P M van Stiphout, et al.
Advances in Radiation Oncology|October 30, 2018
Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapyZhi Cheng, Lauren M Rosati, Linda Chen, et al.
Pageof 124